ARCHIVES

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

This article is from The Cancer Letter archive.

Vol. 20 No. 41 | October 28, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Russos of Michigan Move To Fox Chase; Becker Named To Endowed Chair; NCI’s David Byar Dies

August 23, 1991

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

Panel Urges New Research Consortium For Stomach, Esophageal Cancers

January 17, 2003

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

Chromosomal Abnormalities Predict Long Median Survival

January 27, 2012